BiotechTube
Home/Parabilis Medicines/Mathai Mammen, M.D., Ph.D.
MM

Mathai Mammen, M.D., Ph.D.

CEO, President and Chairman

Parabilis Medicines

Therapeutic Areas

Oncology

Parabilis Medicines Pipeline

DrugIndicationPhase
zolucatetide (FOG-001)Desmoid TumorsPhase not specified (Clinical)